Tisokinase

Drug Profile

Tisokinase

Alternative Names: AK 124; Hapase; Plasvata

Latest Information Update: 22 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Asahi Kasei
  • Developer Asahi Kasei; Kowa
  • Class Plasminogen activator enzymes; Thrombolytics
  • Mechanism of Action Plasminogen activator stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Intracranial thrombosis; Myocardial infarction

Most Recent Events

  • 15 Jan 2001 Asahi Chemical is now called Asahi Kasei
  • 12 Jan 1996 Launched for Cerebral thrombosis in Japan (IV)
  • 05 Jan 1996 Launched for Myocardial infarction in Japan (Intra-arterial)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top